Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- First line therapy therapy protocol distrubition
研究概览
简要总结
A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey
详细描述
The purpose of this study is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed as CLL
- •18 years or older
- •Able and willing to provide the written informed consent
排除标准
- •Younger than 18 years
结局指标
主要结局
First line therapy therapy protocol distrubition
时间窗: 36 months
The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting
次要结局
未报告次要终点
研究者
Fatih Demirkan, MD
Board member
Izmir Hematologic Diseases and Cancer Research Help Association